arrow
A

Ando, Yuichi

Nagoya University
H指数:0
被引数:17

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Abdominal pain accompanied by elevated serum inflammatory markers and biliary enzymes for diagnosing immune checkpoint inhibitor-induced sclerosing cholangitis
2023-05-123
OA
Elevated TSH Level, TgAb, and Prior Use of Ramucirumab or TKIs as Risk Factors for Thyroid Dysfunction in PD-L1 Blockade
2022-08-0313
OA
Increased Risk of Thyroid Dysfunction by PD-1 and CTLA-4 Blockade in Patients Without Thyroid Autoantibodies at Baseline
2021-11-1520
OA
Phase I Assessment of Safety and Therapeutic Activity of BAY1436032 in Patients with IDH1-Mutant Solid Tumors

BAY1436032在IDH1-Mutant实体瘤患者中的安全性和治疗活性的I期评估

2021-02-2342
OA
Randomised phase II trial of capecitabine plus oxaliplatin with continuous versus intermittent use of oxaliplatin as adjuvant chemotherapy for stage II/III colon cancer (CCOG-1302 study)
2021-02-015
PREAI
Pituitary dysfunction induced by immune checkpoint inhibitors is associated with better overall survival in both malignant melanoma and non-small cell lung carcinoma: a prospective study
2020-06-3087
OAAI
Real world data of liver injury induced by immune checkpoint inhibitors in Japanese patients with advanced malignancies

日本晚期恶性肿瘤患者免疫检查点抑制剂诱导肝损伤的真实世界数据

2020-03-0251
PREAI
Anti-thyroid antibodies and thyroid echo pattern at baseline as risk factors for thyroid dysfunction induced by anti-programmed cell death-1 antibodies: a prospective study

基线时的抗甲状腺抗体和甲状腺超声声像图特征作为抗程序性细胞死亡蛋白-1抗体所致甲状腺功能障碍的风险因素:一项前瞻性研究

2020-02-0356
OAAI